Camel milk as a potential therapy as an antioxidant in autism spectrum disorder (ASD)

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Al Ayadhi, Laila Y ^a   Elamin, Nadra Elyass ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; GLUTATHIONE; MYELOPEROXIDASE; SUPEROXIDE DISMUTASE;

ARTICLE; AUTISM; BLOOD LEVEL; CAMEL; CHILD; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; MILK; OXIDATIVE STRESS; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHOOL CHILD;

EID: 84884222783     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/602834     Document Type: Article

References (56)

1. Lord C., Cook E. H., Leventhal B. L., Amaral D. G., Autism spectrum disorders. Neuron 2000 28 2 355 363 2-s2.0-0033635743
2. American Psychiatric Association, Diagnostic and statistical manual of mental disorders. 2000 DSM-IV-TR Washington, DC, USA American Psychiatric Association
3. Momeni N., Bergquist J., Brudin L., Behnia F., Sivberg B., Joghataei M. T., Persson B. L., A novel blood-based biomarker for detection of autism spectrum disorders. Translational Psychiatry 2012 2 article e91 2-s2.0-84858021906 10.1038/tp.2012.19
4. Veenstra-VanderWeele J., Cook E. H. Jr., Molecular genetics of autism spectrum disorder. Molecular Psychiatry 2004 9 9 819 832 2-s2.0-4644285329 10.1038/sj.mp.4001505
5. Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Pessah I., Van de Water J., Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain, Behavior, and Immunity 2011 25 1 40 45 2-s2.0-78649322790 10.1016/j.bbi.2010.08.003
6. AL-Ayadhi L. Y., Mostafa G. A., A lack of association between elevated serum levels of S100B protein and autoimmunity in autistic children. Journal of Neuroinflammation 2012 9 article 54 2-s2.0-84858185562 10.1186/1742-2094-9-54
7. White J. F., Intestinal pathophysiology in autism. Experimental Biology and Medicine 2003 228 6 639 649 2-s2.0-0038505266
8. Bölte S., Poustka F., The relation between general cognitive level and adaptive behavior domains in individuals with autism with and without co-morbid mental retardation. Child Psychiatry and Human Development 2002 33 2 165 172 2-s2.0-0036889063 10.1023/A:1020734325815
9. Baio J., Prevalence of Autism spectrum disorders-autism and developmental disabilities monitoring network, 14 Sites, United States, 2008. Morbidity and Mortality Weekly Report 2012 61 3 1 19 2-s2.0-84859394070
10. Al-Gadani Y., El-Ansary A., Attas O., Al-Ayadhi L., Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children. Clinical Biochemistry 2009 42 10-11 1032 1040 2-s2.0-67349230153 10.1016/j.clinbiochem.2009.03.011
11. Schopler E., Reichler R. J., Renner B. R., The childhood autism rating scale. Western Psychology Services, Los Angeles, Calif, USA
12. Castelloe P., Dawson G., Subclassification of children with autism and pervasive developmental disorder: a questionnaire based on Wing's subgrouping scheme. Journal of Autism and Developmental Disorders 1993 23 2 229 242 2-s2.0-0027300654
13. Chauhan A., Chauhan V., Brown W. T., Cohen I., Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin-the antioxidant proteins. Life Sciences 2004 75 21 2539 2549 2-s2.0-4444347472 10.1016/j.lfs.2004.04.038
14. Christen Y., Oxidative stress and Alzheimer disease. American Journal of Clinical Nutrition 2000 71 2 621s 629s 2-s2.0-0033954991
15. Kannan K., Jain S. K., Oxidative stress and apoptosis. Pathophysiology 2000 7 3 153 163 2-s2.0-0033805442 10.1016/S0928-4680(00)00053-5
16. Bostantjopoulou S., Kyriazis G., Katsarou Z., Kiosseoglou G., Kazis A., Mentenopoulos G., Superoxide dismutase activity in early and advanced Parkinson's disease. Functional Neurology 1997 12 2 63 68 2-s2.0-0030921419
17. Akyol Ö., Herken H., Uz E., Fadilliolu E., Ünal S., Söüt S., Özyurt H., Savaş H. A., The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients: the possible role of oxidant/antioxidant imbalance. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2002 26 5 995 1005 2-s2.0-0036592438 10.1016/S0278-5846(02)00220-8
18. Andreazza A. C., Kauer-Sant'Anna M., Frey B. N., Bond D. J., Kapczinski F., Young L. T., Yatham L. N., Oxidative stress markers in bipolar disorder: a meta-analysis. Journal of Affective Disorders 2008 111 2-3 135 144 2-s2.0-51349085199 10.1016/j.jad.2008.04.013
19. Shohami E., Beit-Yannai E., Horowitz M., Kohen R., Oxidative stress in closed-head injury: brain antioxidant capacity as an indicator of functional outcome. Journal of Cerebral Blood Flow and Metabolism 1997 17 10 1007 1019 2-s2.0-0030770947
20. El-Ansary A., Al-Daihan S., Al-Dbass A., Al-Ayadhi L., Measurement of selected ions related to oxidative stress and energy metabolism in Saudi autistic children. Clinical Biochemistry 2010 43 1-2 63 70 2-s2.0-72649091920 10.1016/j.clinbiochem.2009.09.008
21. Zoroglu S. S., Armutcu F., Ozen S., Gurel A., Sivasli E., Yetkin O., Meram I., Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism. European Archives of Psychiatry and Clinical Neuroscience 2004 254 3 143 147 2-s2.0-4243077662 10.1007/s00406-004- 0456-7
22. Russo A. J., Decreased serum Cu/Zn SOD in children with autism. Nutrition and Metabolic Insights 2009 2 27 35
23. Meguid N. A., Dardir A. A., Abdel-Raouf E. R., Hashish A., Evaluation of oxidative stress in autism: defective antioxidant enzymes and increased lipid peroxidation. Biological Trace Element Research 2011 143 1 58 65 2-s2.0-80054773490 10.1007/s12011-010-8840-9
24. Al-Yafee Y. A., Al-Ayadhi L. Y., Haq S. H., El-Ansary A. K., Novel metabolic biomarkers related to sulfur-dependent detoxification pathways in autistic patients of Saudi Arabia. BMC Neurology 2011 11 article 139 2-s2.0-80155137252 10.1186/1471-2377-11-139
25. Al-Mosalem O. A., El-Ansary A., Attas O., Al-Ayadhi L., Metabolic biomarkers related to energy metabolism in Saudi autistic children. Clinical Biochemistry 2009 42 10-11 949 957 2-s2.0-67349211024 10.1016/j.clinbiochem. 2009.04.006
26. McGinnis W. R., Oxidative stress in autism. Integrative Medicine 2005 3 6 42 57
27. Agrawal R. P., Beniwal R., Kochar D. K., Tuteja F. C., Ghorui S. K., Sahani M. S., Sharma S., Camel milk as an adjunct to insulin therapy improves long-term glycemic control and reduction in doses of insulin in patients with type-1 diabetes: a 1 year randomized controlled trial. Diabetes Research and Clinical Practice 2005 68 2 176 177 2-s2.0-18044376224 10.1016/j.diabres.2004. 12.007
28. Agrawal R. P., Jain S., Shah S., Chopra A., Agarwal V., Effect of camel milk on glycemic control and insulin requirement in patients with type 1 diabetes: 2-years randomized controlled trial. European Journal of Clinical Nutrition 2011 65 9 1048 1052 2-s2.0-80052588685 10.1038/ejcn.2011.98
29. Saltanat H., Li H., Xu Y., Wang J., Liu F., Geng X.-H., The influences of camel milk on the immune response of chronic hepatitis B patients. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2009 25 5 431 433 2-s2.0-77949325337
30. Shabo Y., Yagil R., Etiology of autism and camel milk as therapy. Journal of Endocrine Genetics 2005 4 2 67 70 2-s2.0-33751212446
31. Yagil R., Camel milk and autoimmune diseases: historical medicine. 2004, http://www.camelmilkforhealth.com
32. Mohamed H. E., Mousa H. M., Beynen A. C., Ascorbic acid concentrations in milk from Sudanese camels. Journal of Animal Physiology and Animal Nutrition 2005 89 1-2 35 37 2-s2.0-13944262914 10.1111/j.1439-0396.2004.00507.x
33. Al-Humaid A. I., Mousa H. M., El-Mergawi R. A., Abdel-Salam A. M., Chemical composition and antioxidant activity of dates and dates-camel-milk mixtures as a protective meal against lipid peroxidation in rats. American Journal of Food Technology 2010 5 1 22 30 2-s2.0-74949108338 10.3923/ajft.2010.22.30
34. Shabo Y., Barzel R., Margoulis M., Yagil R., Camel milk for food allergies in children. Israel Medical Association Journal 2005 7 12 796 798 2-s2.0-29444443127
35. Kappeler S., Farah Z., Puhan Z., Sequence analysis of Camelus dromedarius milk caseins. The Journal of Dairy Research 1998 65 2 209 222 2-s2.0-0032077925 10.1017/S0022029997002847
36. Kappeler S., Compositional and structural analysis of camel milk proteins with emphasis on protective proteins [Ph.D. thesis] 1998 Zurich, Switzerland Swiss Federal Institute of Technology
37. Zafra O., Fraile S., Gutiérrez C., Haro A., Páez-Espino A. D., Jiménez J. I., De Lorenzo V., Monitoring biodegradative enzymes with nanobodies raised in Camelus dromedarius with mixtures of catabolic proteins. Environmental Microbiology 2011 13 4 960 974 2-s2.0-79951933331 10.1111/j.1462-2920.2010.02401.x
38. Rose S., Melnyk S., Pavliv O., Bai S., Nick T. G., Frye R. E., James S. J., Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Transl Psychiatry 2012 2 e134 10.1038/tp.2012.61
39. McGinnis W. R., Oxidative stress in autism. Alternative Therapies in Health and Medicine 2004 10 6 22 36 2-s2.0-16644381478
40. Söüt S., Zorolu S. S., Özyurt H., Yilmaz H. R., Özuurlu F., Sivasli E., Yetkin Ö., Yanik M., Tutkun H., Savaş H. A., Tarakçiolu M., Akyol Ö., Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. Clinica Chimica Acta 2003 331 1-2 111 117 2-s2.0-12444304256 10.1016/S0009-8981(03)00119-0
41. Yorbik O., Sayal A., Akay C., Akbiyik D. I., Sohmen T., Investigation of antioxidant enzymes in children with autistic disorder. Prostaglandins Leukotrienes and Essential Fatty Acids 2002 67 5 341 343 2-s2.0-6444245957 10.1054/plef.2002.0439
42. Knivsberg A., Reichelt K. L., Nodland N., Hoien T., Autistic syndromes and diet: a follow-up study. Scandinavian Journal of Educational Research 1995 39 223 236
43. Knivsberg A. M., Reichelt K. L., Høien T., Nødland M., A randomised, controlled study of dietary intervention in autistic syndromes. Nutritional Neuroscience 2002 5 4 251 261 2-s2.0-0035988633 10.1080/ 10284150290028945
44. Al-Ayadhi L. Y., Mostafa G. A., Elevated serum levels of macrophage-derived chemokine and thymus and activation-regulated chemokine in autistic children. Journal of Neuroinflammation 2013 10 article 72 1
45. Al-wabel N. A., Hassan A., Abbas H., Muosa H., Antiulcerogenic effect of camel milk against ethanol induced gastric ulcers in rats. WebmedCentral Veterinary Medicine 2012 3 3 WMC002804
46. Klevay L., Schrauzer G. N., Advances in cardiovascular-copper research. Proceedings of the 1st International Bio-Minerals Symposium: Trace Elements in Nutrition, Health and Disease 2003 Montreal, Canada Institute Rosell
47. Powell S. R., The antioxidant properties of zinc. Journal of Nutrition 2000 130 5 1447 1454 2-s2.0-0034099055
48. Faber S., Zinn G. M., Kern J. C. II, Skip Kingston H. M., The plasma zinc/serum copper ratio as a biomarker in children with autism spectrum disorders. Biomarkers 2009 14 3 171 180 2-s2.0-66149089999 10.1080/ 13547500902783747
49. Kurutas E. B., Cetinkaya A., Bulbuloglu E., Kantarceken B., Effects of antioxidant therapy on leukocyte myeloperoxidase and Cu/Zn-superoxide dismutase and plasma malondialdehyde levels in experimental colitis. Mediators of Inflammation 2005 2005 6 390 394 2-s2.0-29144454969 10.1155/MI.2005.390
50. Green P. S., Mendez A. J., Jacob J. S., Crowley J. R., Growdon W., Hyman B. T., Heinecke J. W., Neuronal expression of myeloperoxidase is increased in Alzheimer's disease. Journal of Neurochemistry 2004 90 3 724 733 2-s2.0-3343003470 10.1111/j.1471-4159.2004.02527.x
51. Choi D.-K., Pennathur S., Perier C., Tieu K., Teismann P., Wu D.-C., Jackson-Lewis V., Vila M., Vonsattel J.-P., Heinecke J. W., Przedborski S., Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice. Journal of Neuroscience 2005 25 28 6594 6600 2-s2.0-22244434468 10.1523/JNEUROSCI.0970-05.2005
52. Nagra R. M., Becher B., Tourtellotte W. W., Antel J. P., Gold D., Paladino T., Smith R. A., Nelson J. R., Reynolds W. F., Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. Journal of Neuroimmunology 1997 78 1-2 97 107 2-s2.0-0030764896 10.1016/S0165-5728(97) 00089-1
53. Anthony A. K., Russo J., Jepson B., Wakefield A., Low serum myeloperoxidase in autistic children with gastrointestinal disease. Journal of Clinical and Experimental Gastroenterology 2009 2 85 94
54. Horvath K., Perman J. A., Autistic disorder and gastrointestinal disease. Current Opinion in Pediatrics 2002 14 5 583 587 2-s2.0-0036786387 10.1097/00008480-200210000-00004
55. Rahman I., Biswas S. K., Jimenez L. A., Torres M., Forman H. J., Glutathione, stress responses, and redox signaling in lung inflammation. Antioxidants and Redox Signaling 2005 7 1-2 42 59 2-s2.0-13244269755 10.1089/ars.2005.7.42
56. El Heni J., Sfar S., Hammouda F., Sfar M. T., Kerkeni A., Interrelationships between cadmium, zinc and antioxidants in the liver of the rat exposed orally to relatively high doses of cadmium and zinc. Ecotoxicology and Environmental Safety 2011 74 7 2099 2104 2-s2.0-80053133070 10.1016/j.ecoenv.2011.06.008